A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted AngiomaInterventions: Drug: Vincristine; Drug: SirolimusSponsors: Children's Hospital Medical Center, Cincinnati; PfizerNot yet recruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials